← Leaderboards
Brian Magne Andersen
University Of Minnesota
$92,390
Attributed
$92,390
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $47.7K · FY2013–15$50K$37.5K$25K$12.5K$0
'13
'14
'15
Funding mix
By agency
NIH$92,390 · 1
By mechanism
F30$92,390 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- David Dale Thomas$44,926,284
- Melena D. Bellin$14,599,542
- Bruce R. Blazar$144,460,093
- Brian T Fife$14,145,163
- Mark D Distefano$11,695,253
Others in their field
Top investigators on “Adjuvanticity”
- Jay Evans · Corixa Corporation$13,735,700
- Nikolai Petrovsky · Vaxine Pty Ltd$10,786,491
- Luc Teyton · Scripps Research Institute, The$7,236,382
- Daniel A Portnoy · University Of California Berkeley$5,722,263
- Lee Mark Wetzler · Boston Medical Center$5,497,489
- Ofer Levy · Brigham And Women'S Hospital$5,439,291
Research focus
AdjuvanticityAffectAnnexin A2AnnexinsAntigen ProcessingAntigensBaseBasic ScienceBinding (Molecular Function)BrainBrain NeoplasmsCancer Immunology ScienceCancer TherapyCancer VaccinesCareerCd8b1 GeneCell Culture TechniquesCellsClinical TrialsCross PresentationCross-PrimingCultured Tumor CellsDendritic CellsAdjuvant
Grant awards (3)
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing$2,482
F30 · FY2015 · CA · contact PI
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing$47,676
F30 · FY2014 · CA · contact PI
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing$42,232
F30 · FY2013 · CA · contact PI